VALVOSOFT® Pivotal Study

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 15, 2022

Primary Completion Date

August 17, 2023

Study Completion Date

July 24, 2024

Conditions
Aortic Valve CalcificationAortic Valve Stenosis
Interventions
DEVICE

VALVOSFT intervention

Treatment of the calcific aorta valve by non-invasive ultrasound therapy

Trial Locations (11)

31076

Clinique Pasteur, Toulouse

61231

Kerckhoff-klinik, Bad Nauheim

Unknown

CHU Lille Insitut Coeur Poumon, Lille

Hopital Bichat Claude-Bernard, Paris

Hopital Europeen Georges Pompidou, Paris

CHU Reims Hopital Robert Debré, Reims

CHU Rouen Hopital Charles Nicole, Rouen

Marienkrankenhaus, Hamburg

Amphia Hospital, Breda

1091 AC

OLVG, Amsterdam

6525 AG

Radboudumc, Nijmegen

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

QbD Clinical

INDUSTRY

lead

Cardiawave SA

INDUSTRY

NCT05235568 - VALVOSOFT® Pivotal Study | Biotech Hunter | Biotech Hunter